個人中心
登出
中文繁體
返回
登入後諮詢在線客服
回到頂部

NEWS

AVITA Medical Announces FDA Approval of RECELL GO
AVITA Medical announced FDA approval for its advanced autologous cell harvesting device, RECELL GO. This next-gen device improves treatment for thermal burn wounds and full-thickness skin defects by harnessing a patient's own skin. Key advantages include faster healing, reduced pain, improved aesthetics, and fewer procedures. Enhanced features streamline the preparation of Spray-On Skin Cells and improve workflow efficiency. RECELL GO will launch in top U.S. burn centers in June, with broader adoption expected through the year.
免責聲明:社區由Moomoo Technologies Inc.提供,僅用於教育目的。 更多信息
翻譯
舉報
瀏覽 3376
評論
登錄發表評論
    Spread kindness and love. Life is short. Don’t let greed eat you.
    2537粉絲
    107關注
    2.8萬來訪
    關注